SBI Okasan Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

SBI Okasan Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.29M	Hold	22,000	–	–	0.04%	103
2026 Q1	$1.31M	Hold	22,000	–	–	0.05%	71
2025 Q4	$1.19M	Buy	+22,000	New	+$1.06M	0.07%	100

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

SBI Okasan Asset Management's BMY Position: Q2 2026 in Review

SBI Okasan Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 22,000 shares worth $1.29M. The position accounts for 0.04% of the portfolio, ranked #103.

SBI Okasan Asset Management first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.31M in Q1 2026. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

SBI Okasan Asset Management held 22,000 shares of Bristol-Myers Squibb worth $1.29M as of Q2 2026.
SBI Okasan Asset Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.04% of SBI Okasan Asset Management's portfolio in Q2 2026, its #103 holding.
SBI Okasan Asset Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
SBI Okasan Asset Management's Bristol-Myers Squibb position peaked at $1.31M in Q1 2026.
2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on SBI Okasan Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.